LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 37

Search options

  1. Article: The antiaging property of aqueous extract of

    Jumnongprakhon, Pichaya / Pinkaew, Decha / Phuneerub, Pravaree

    Journal of advanced pharmaceutical technology & research

    2021  Volume 12, Issue 1, Page(s) 14–21

    Abstract: Cellular senescence is the key mediator of cellular dysfunction before undergoing degenerative disease such as Alzheimer's disease. The aging process was mainly by the overactivation of senescence associated β-galactosidase (SA-β-gal) enzyme before ... ...

    Abstract Cellular senescence is the key mediator of cellular dysfunction before undergoing degenerative disease such as Alzheimer's disease. The aging process was mainly by the overactivation of senescence associated β-galactosidase (SA-β-gal) enzyme before mediated several negative responses, including intracellular reactive oxygen species (ROS) production, cellular senescence regulation, and death prior encourage synaptic loss. Thus, in the recent work, we evaluated the
    Language English
    Publishing date 2021-01-09
    Publishing country India
    Document type Journal Article
    ISSN 2231-4040
    ISSN 2231-4040
    DOI 10.4103/japtr.JAPTR_187_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

    Pinkaew, Decha / Fujise, Ken

    Advances in clinical chemistry

    2017  Volume 82, Page(s) 265–300

    Abstract: Fortilin is a highly conserved 172-amino-acid polypeptide found in the cytosol, nucleus, mitochondria, extracellular space, and circulating blood. It is a multifunctional protein that protects cells against apoptosis, promotes cell growth and cell cycle ... ...

    Abstract Fortilin is a highly conserved 172-amino-acid polypeptide found in the cytosol, nucleus, mitochondria, extracellular space, and circulating blood. It is a multifunctional protein that protects cells against apoptosis, promotes cell growth and cell cycle progression, binds calcium (Ca
    MeSH term(s) Animals ; Atherosclerosis/drug therapy ; Atherosclerosis/prevention & control ; Bacterial Infections/drug therapy ; Bacterial Infections/prevention & control ; Biomarkers/analysis ; Biomarkers, Tumor/analysis ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/prevention & control ; Humans ; Hypertension, Pulmonary/drug therapy ; Hypertension, Pulmonary/prevention & control ; Liver Diseases/drug therapy ; Liver Diseases/prevention & control ; Malaria/drug therapy ; Malaria/prevention & control ; Neoplasms/drug therapy ; Neoplasms/prevention & control ; Virus Diseases/drug therapy ; Virus Diseases/prevention & control
    Chemical Substances Biomarkers ; Biomarkers, Tumor ; tumor protein, translationally-controlled 1
    Language English
    Publishing date 2017-08-07
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 210505-6
    ISSN 0065-2423
    ISSN 0065-2423
    DOI 10.1016/bs.acc.2017.06.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Fortilin inhibits p53, halts cardiomyocyte apoptosis, and protects the heart against heart failure.

    Chunhacha, Preedakorn / Pinkaew, Decha / Sinthujaroen, Patuma / Bowles, Dawn E / Fujise, Ken

    Cell death discovery

    2021  Volume 7, Issue 1, Page(s) 310

    Abstract: Heart failure (HF) has reached epidemic proportions in developed countries, affecting over 20 million people worldwide. Despite modern medical and device therapies, 60-70% of HF patients still die within 5 years of diagnosis as it relentlessly progresses ...

    Abstract Heart failure (HF) has reached epidemic proportions in developed countries, affecting over 20 million people worldwide. Despite modern medical and device therapies, 60-70% of HF patients still die within 5 years of diagnosis as it relentlessly progresses through pervasive apoptotic loss of cardiomyocytes. Although fortilin, a 172-amino-acid anti-p53 molecule, is one of the most expressed proteins in the heart, its precise role there has remained unknown. Also unclear is how cardiomyocytes are protected against apoptosis. Here, we report that failing human hearts express less fortilin than do non-failing hearts. We also found that mice lacking fortilin in the heart (fortilin
    Language English
    Publishing date 2021-10-23
    Publishing country United States
    Document type Journal Article
    ISSN 2058-7716
    ISSN 2058-7716
    DOI 10.1038/s41420-021-00692-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Phonophoresis of Phyllanthus amarus nanoparticle gel improves functional capacity in individuals with knee osteoarthritis: A randomized controlled trial.

    Pinkaew, Decha / Kiattisin, Kanokwan / Wonglangka, Khanittha / Awoot, Pisittawoot

    Journal of bodywork and movement therapies

    2019  Volume 24, Issue 1, Page(s) 15–18

    Abstract: Objective: This study examined the effects of treatment with Phyllanthus amarus nanoparticle gel applied by phonophoresis (PP) and ultrasound therapy (UT) in patients with symptomatic knee osteoarthritis (OA) using a randomized, double-blind, controlled ...

    Abstract Objective: This study examined the effects of treatment with Phyllanthus amarus nanoparticle gel applied by phonophoresis (PP) and ultrasound therapy (UT) in patients with symptomatic knee osteoarthritis (OA) using a randomized, double-blind, controlled trial.
    Methods: Patients with knee OA (n = 40; mean age ± SD, 64.30 ± 9.71 years), who had visual analogue scale (VAS) scores for knee pain intensity of 68.00 ± 9.58 (UT group) and 71.00 ± 8.74 (PP group, respectively) before treatment, were randomly allocated into two groups. Both groups were treated with an ultrasound program in continuous mode, 1.0 W/cm
    Results: VAS and 6-MWT showed significant improvement after treatment in both groups (p < 0.05). The PP group showed more significant effects than the UT group, in terms of both reducing the VAS pain score (p < 0.05) and improving 6-MWT (p < 0.05).
    Conclusions: PP is suggested as an effective method for the treatment of symptomatic knee OA for reducing pain and improving functional capacity.
    MeSH term(s) Administration, Cutaneous ; Aged ; Combined Modality Therapy ; Double-Blind Method ; Female ; Humans ; Knee Joint/physiopathology ; Male ; Middle Aged ; Osteoarthritis, Knee/therapy ; Pain Measurement ; Phonophoresis/methods ; Phyllanthus ; Skin Cream/therapeutic use ; Time Factors ; Treatment Outcome ; Ultrasonic Therapy/methods
    Language English
    Publishing date 2019-05-04
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2029441-4
    ISSN 1532-9283 ; 1360-8592
    ISSN (online) 1532-9283
    ISSN 1360-8592
    DOI 10.1016/j.jbmt.2019.04.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Phonopheresis Associated with Nanoparticle Gel from Phyllanthus amarus Relieves Pain by Reducing Oxidative Stress and Proinflammatory Markers in Adults with Knee Osteoarthritis.

    Decha, Pinkaew / Kanokwan, Kiattisin / Jiraporn, Tocharus / Pichaya, Jumnongprakhon / Pisittawoot, Awoot

    Chinese journal of integrative medicine

    2019  Volume 25, Issue 9, Page(s) 691–695

    Abstract: Objective: To determine the changes in serum levels of inflammatory biomarkers and antioxidant levels among the knee osteoarthritis (OA) patients after treatment with Phyllanthus amarus (PP) by nanoparticle gel phonophoresis.: Methods: This study was ...

    Abstract Objective: To determine the changes in serum levels of inflammatory biomarkers and antioxidant levels among the knee osteoarthritis (OA) patients after treatment with Phyllanthus amarus (PP) by nanoparticle gel phonophoresis.
    Methods: This study was a randomized, double-blind, placebo-control, parallel-group, clinical trial involving 30 subjects with mild-to-moderate degree of knee OA. The patients were allocated to two groups using a computer-generated random numbers, and received conventional ultrasound therapy (control group, 15 cases) and PP (treatment group, 15 cases) once daily for 10 sessions. The pain was evaluated by visual analogue scale (VAS). Serum levels of tumor necrosis factor-α (TNF-α) were determined by enzyme-linked immunosorbnent assay (ELISA). Nitric oxide (NO) was determined by modified Griess reagent. The antioxidant effects, including superoxide dismutase (SOD) and total antioxidant capacity (TAC), were also measured by ELISA assay.
    Results: The VAS score was significantly decreased in the treatment group compared with the control group after treatment (P<0.01). The serum concentrations of TNF-α and NO were significantly reduced in the treatment group compared with the control group (P<0.01) after treatment. However, the serum concentrations of SOD and TAC in the treatment group were significantly higher after treatment compared with the control group (P<0.01).
    Conclusion: PP could alleviate knee pain and significantly reduce systemic anti-inflammatory effects in knee OA patients.
    MeSH term(s) Adult ; Aged ; Antioxidants/metabolism ; Biomarkers/metabolism ; Gels/therapeutic use ; Humans ; Inflammation Mediators/metabolism ; Middle Aged ; Nanoparticles/chemistry ; Nitrates/metabolism ; Nitrites/metabolism ; Osteoarthritis, Knee/complications ; Osteoarthritis, Knee/pathology ; Osteoarthritis, Knee/therapy ; Oxidative Stress ; Pain/etiology ; Pain Measurement ; Phyllanthus/chemistry ; Superoxide Dismutase/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Ultrasonics
    Chemical Substances Antioxidants ; Biomarkers ; Gels ; Inflammation Mediators ; Nitrates ; Nitrites ; Tumor Necrosis Factor-alpha ; Superoxide Dismutase (EC 1.15.1.1)
    Language English
    Publishing date 2019-10-24
    Publishing country China
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2171254-2
    ISSN 1993-0402 ; 1672-0415
    ISSN (online) 1993-0402
    ISSN 1672-0415
    DOI 10.1007/s11655-019-3202-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Effects of a simple prototype respiratory muscle trainer on respiratory muscle strength, quality of life and dyspnea, and oxidative stress in COPD patients: a preliminary study.

    Leelarungrayub, Jirakrit / Pinkaew, Decha / Puntumetakul, Rungthip / Klaphajone, Jakkrit

    International journal of chronic obstructive pulmonary disease

    2017  Volume 12, Page(s) 1415–1425

    Abstract: Background: The aim of this study was to evaluate the efficiency of a simple prototype device for training respiratory muscles in lung function, respiratory muscle strength, walking capacity, quality of life (QOL), dyspnea, and oxidative stress in ... ...

    Abstract Background: The aim of this study was to evaluate the efficiency of a simple prototype device for training respiratory muscles in lung function, respiratory muscle strength, walking capacity, quality of life (QOL), dyspnea, and oxidative stress in patients with COPD.
    Methods: Thirty COPD patients with moderate severity of the disease were randomized into three groups: control (n=10, 6 males and 4 females), standard training (n=10, 4 males and 6 females), and prototype device (n=10, 5 males and 5 females). Respiratory muscle strength (maximal inspiratory pressure [PImax] and maximal expiratory pressure [PEmax]), lung function (forced vital capacity [FVC], percentage of FVC, forced expiratory volume in 1 second [FEV
    Results: All parameters between the groups had no statistical difference before training, and no statistical change in the control group after week 6. FVC, FEV
    Conclusion: This study proposes that a simple prototype device can be used clinically in COPD patients as a standard device to train respiratory muscles, improving lung function and QOL, as well as involving MDA and NO levels.
    Language English
    Publishing date 2017
    Publishing country New Zealand
    Document type Journal Article
    ISSN 1178-2005
    ISSN (online) 1178-2005
    DOI 10.2147/COPD.S131062
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy.

    Ei, Zin Zin / Choochuay, Kanuengnit / Tubsuwan, Alisa / Pinkaew, Decha / Suksomtip, Maneewan / Vinayanuwattikun, Chanida / Chanvorachote, Pithi / Chunhacha, Preedakorn

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 22448

    Abstract: Cisplatin (CDDP) induces senescence characterized by senescence-associated secretory phenotypes (SASP) and the unfolded protein response (UPR). In this study, we investigated the proteins related to the UPR during the senescence cell fate. Strikingly, we ...

    Abstract Cisplatin (CDDP) induces senescence characterized by senescence-associated secretory phenotypes (SASP) and the unfolded protein response (UPR). In this study, we investigated the proteins related to the UPR during the senescence cell fate. Strikingly, we found that one of the critical ER-resident proteins, GRP78/BiP, was significantly altered. Here we show that GRP78 levels differentially expressed depending on non-small lung cancer subtypes. GRP78 indeed regulates the evasion of senescence in adenocarcinoma A549 cells, in which the increased GRP78 levels enable them to re-proliferate after CDDP removal. Conversely, GRP78 is downregulated in the senescence H460 cells, making them lacking senescence evasion capability. We observed that the translational regulation critically contributed to the GRP78 protein levels in CDDP-induces senescence. Furthermore, the increased GRP78 level during senescence confers resistance to senolytic drug, Bortezomib, as observed by a twofold increase in IC
    MeSH term(s) A549 Cells ; Antineoplastic Agents/pharmacology ; Bortezomib/pharmacology ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Cycle/drug effects ; Cell Cycle/genetics ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Cellular Senescence/drug effects ; Cellular Senescence/genetics ; Cisplatin/pharmacology ; Down-Regulation/genetics ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Endoplasmic Reticulum Chaperone BiP/genetics ; Endoplasmic Reticulum Chaperone BiP/metabolism ; Humans ; Inhibitory Concentration 50 ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Transfection ; Unfolded Protein Response/drug effects ; Up-Regulation/genetics
    Chemical Substances Antineoplastic Agents ; Endoplasmic Reticulum Chaperone BiP ; HSPA5 protein, human ; Bortezomib (69G8BD63PP) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2021-11-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-01540-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation

    Decha Pinkaew / Erik Martinez-Hackert / Wei Jia / Matthew D. King / Fei Miao / Nicole R. Enger / Runglawan Silakit / Kota Ramana / Shi-You Chen / Ken Fujise

    Communications Biology, Vol 5, Iss 1, Pp 1-

    2022  Volume 13

    Abstract: Fortilin prevents the activation of the TGF-β1 receptor by occupying the pocket of TGF-β1 and competing with TGF-βRII to bind with TGF-β1. This inhibits Smad3 phosphorylation and the differentiation of C3H10T1/2 mesenchymal progenitor cells to smooth ... ...

    Abstract Fortilin prevents the activation of the TGF-β1 receptor by occupying the pocket of TGF-β1 and competing with TGF-βRII to bind with TGF-β1. This inhibits Smad3 phosphorylation and the differentiation of C3H10T1/2 mesenchymal progenitor cells to smooth muscle cells.
    Keywords Biology (General) ; QH301-705.5
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy

    Zin Zin Ei / Kanuengnit Choochuay / Alisa Tubsuwan / Decha Pinkaew / Maneewan Suksomtip / Chanida Vinayanuwattikun / Pithi Chanvorachote / Preedakorn Chunhacha

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 15

    Abstract: Abstract Cisplatin (CDDP) induces senescence characterized by senescence-associated secretory phenotypes (SASP) and the unfolded protein response (UPR). In this study, we investigated the proteins related to the UPR during the senescence cell fate. ... ...

    Abstract Abstract Cisplatin (CDDP) induces senescence characterized by senescence-associated secretory phenotypes (SASP) and the unfolded protein response (UPR). In this study, we investigated the proteins related to the UPR during the senescence cell fate. Strikingly, we found that one of the critical ER-resident proteins, GRP78/BiP, was significantly altered. Here we show that GRP78 levels differentially expressed depending on non-small lung cancer subtypes. GRP78 indeed regulates the evasion of senescence in adenocarcinoma A549 cells, in which the increased GRP78 levels enable them to re-proliferate after CDDP removal. Conversely, GRP78 is downregulated in the senescence H460 cells, making them lacking senescence evasion capability. We observed that the translational regulation critically contributed to the GRP78 protein levels in CDDP-induces senescence. Furthermore, the increased GRP78 level during senescence confers resistance to senolytic drug, Bortezomib, as observed by a twofold increase in IC50 in A549 senescence cells compared to the wild-type. This observation is also consistent in the cells that have undergone genetic manipulation by transfection with pcDNA3.1(+)-GRP78/BiP plasmids and pSpCas9(BB)-2A-Puro containing guide RNA sequence targeting GRP78 exon 3 to induce the overexpression and downregulation of GRP78 in H460 cells, respectively. Our findings reveal a unique role of GRP78 on the senescence evasion cell fate and senolytic drug resistance after cisplatin-based chemotherapy.
    Keywords Medicine ; R ; Science ; Q
    Subject code 571
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation.

    Pinkaew, Decha / Martinez-Hackert, Erik / Jia, Wei / King, Matthew D / Miao, Fei / Enger, Nicole R / Silakit, Runglawan / Ramana, Kota / Chen, Shi-You / Fujise, Ken

    Communications biology

    2022  Volume 5, Issue 1, Page(s) 157

    Abstract: Fortilin is a 172-amino acid multifunctional protein present in both intra- and extracellular spaces. Although fortilin binds and regulates various cellular proteins, the biological role of extracellular fortilin remains unknown. Here we report that ... ...

    Abstract Fortilin is a 172-amino acid multifunctional protein present in both intra- and extracellular spaces. Although fortilin binds and regulates various cellular proteins, the biological role of extracellular fortilin remains unknown. Here we report that fortilin specifically interacts with TGF-β1 and prevents it from activating the TGF-β1 signaling pathway. In a standard immunoprecipitation-western blot assay, fortilin co-immunoprecipitates TGF-β1 and its isoforms. The modified ELISA assay shows that TGF-β1 remains complexed with fortilin in human serum. Both bio-layer interferometry and surface plasmon resonance (SPR) reveal that fortilin directly bind TGF-β1. The SPR analysis also reveals that fortilin and the TGF-β receptor II (TGFβRII) compete for TGF-β1. Both luciferase and secreted alkaline phosphatase reporter assays show that fortilin prevents TGF-β1 from activating Smad3 binding to Smad-binding element. Fortilin inhibits the phosphorylation of Smad3 in both quantitative western blot assays and ELISA. Finally, fortilin inhibits TGFβ-1-induced differentiation of C3H10T1/2 mesenchymal progenitor cells to smooth muscle cells. A computer-assisted virtual docking reveals that fortilin occupies the pocket of TGF-β1 that is normally occupied by TGFβRII and that TGF-β1 can bind either fortilin or TGFβRII at any given time. These data support the role of extracellular fortilin as a negative regulator of the TGF-β1 signaling pathway.
    MeSH term(s) Humans ; Phosphorylation ; Receptors, Transforming Growth Factor beta/metabolism ; Signal Transduction ; Transforming Growth Factor beta1/metabolism ; Tumor Protein, Translationally-Controlled 1/metabolism
    Chemical Substances Receptors, Transforming Growth Factor beta ; TGFB1 protein, human ; TPT1 protein, human ; Transforming Growth Factor beta1 ; Tumor Protein, Translationally-Controlled 1
    Language English
    Publishing date 2022-02-23
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-022-03112-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top